Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, Alembic Pharmaceuticals has informed that the Company has acquired Series Seed Preferred Stock of RIGlmmune, Inc. In this regard, the company enclosed a press release. The detailed disclosure pursuant to Regulation 30(2) of the aforesaid Regulations is also enclosed as Annexure-1.
The above information is a part of company’s filings submitted to BSE.